Psychiatry Research: Neuroimaging
Volume 181, Issue 3 , Pages 237-240 , 30 March 2010

High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: A longitudinal 31P MRS study of basal ganglia

  • Peruvumba N. Jayakumar

      Affiliations

    • Department of Neuroimaging & Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India
    • ,
  • Bangalore N. Gangadhar

      Affiliations

    • Department of Psychiatry, National Institute of Mental Health & Neurosciences, Bangalore, 560029, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 80 26995260; fax: +91 80 26564830.
    • ,
  • Ganesan Venkatasubramanian

      Affiliations

    • Department of Psychiatry, National Institute of Mental Health & Neurosciences, Bangalore, 560029, India
    • ,
  • Sunali Desai

      Affiliations

    • Department of Neuroimaging & Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India
    • ,
  • Latha Velayudhan

      Affiliations

    • Department of Psychiatry, National Institute of Mental Health & Neurosciences, Bangalore, 560029, India
    • ,
  • Dattathreya Subbakrishna

      Affiliations

    • Department of Biostatistics, National Institute of Mental Health and Neurosciences, Bangalore, India
    • ,
  • Matcheri S. Keshavan

      Affiliations

    • Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, USA
    • Department of Psychiatry, Beth Israel Deaconess Medical Center Landmark Building, 401 Park Avenue, Boston, MA 02215, USA

Received 19 April 2009 ,Revised 30 August 2009 ,Accepted 16 October 2009.

References 

  1. Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biological Psychiatry. 2001;49:39–46
  2. Bustillo JR, Lauriello J, Rowland LM, Jung RE, Petropoulos H, Hart BL, et al. Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. Psychiatry Research: Neuroimaging. 2001;107:135–149
  3. Bustillo JR, Lauriello J, Rowland LM, Thomson LM, Petropoulos H, Hammond R, et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophrenia Research. 2002;58:313–321
  4. Bustillo JR, Rowland LM, Jung R, Brooks WM, Qualls C, Hammond R, et al. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia. Neuropsychopharmacology. 2008;33:2456–2466
  5. Deicken RF, Calabrese G, Merrin EL, Meyerhoff DJ, Dillon WP, Weiner MW, et al. 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biological Psychiatry. 1994;36:503–510
  6. Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophrenia Research. 2000;41:389–395
  7. Erecinska M, Silver IA. ATP and brain function. Journal of Cerebral Blood Flow and Metabolism. 1989;9:2–19
  8. Fannon D, Simmons A, Tennakoon L, O'Ceallaigh S, Sumich A, Doku V, et al. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biological Psychiatry. 2003;54:587–598
  9. Gangadhar BN, Jayakumar PN, Subbakrishna DK, Janakiramaiah N, Keshavan MS. Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. American Journal of Psychiatry. 2004;161:1304–1306
  10. Goto N, Yoshimura R, Moriya J, Kakeda S, Ueda N, Ikenouchi-Sugita A, et al. Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study. Schizophrenia Research. 2009;112:192–193
  11. Jayakumar PN, Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Srinivas JS, Keshavan MS. Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study. Biological Psychiatry. 2003;54:491–494
  12. Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, et al. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla. Psychiatry Research: Neuroimaging. 2006;146:127–135
  13. Kemp GJ. Non-invasive methods for studying brain energy metabolism: what they show and what it means. Developmental Neuroscience. 2000;22:418–428
  14. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. Lancet. 1994;344:1434
  15. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. American Journal of Psychiatry. 1998;155:774–778
  16. Klunk WE, Xu CJ, Panchalingam K, McClure RJ, Pettegrew JW. Analysis of magnetic resonance spectra by mole percent: comparison to absolute units. Neurobiology of Aging. 1994;15:133–140
  17. Klushnik TP, Spunde A, Yakovlev AG, Khuchua ZA, Saks VA, Vartanyan ME. Intracellular alterations of the creatine kinase isoforms in brains of schizophrenic patients. Molecular Chemistry and Neuropathology. 1991;15:271–280
  18. Leung TK, Hall C, Monfries C, Lim L. Trifluoperazine activates and releases latent ATP-generating enzymes associated with the synaptic plasma membrane. Journal of Neurochemistry. 1987;49:232–238
  19. Sauter A, Rudin M. Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer Correlation with brain function. Journal of Biological Chemistry. 1993;268:13166–13171
  20. Volz HP, Rossger G, Riehemann S, Hubner G, Maurer I, Wenda B, et al. Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic study. Biological Psychiatry. 1999;45:1221–1225
  21. Volz HP, Rzanny R, Rossger G, Hubner G, Kreitschmann-Andermahr I, Kaiser WA, et al. Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study. Psychiatry Research: Neuroimaging. 1997;76:123–129

PII: S0925-4927(09)00243-1

doi: 10.1016/j.pscychresns.2009.10.010

Psychiatry Research: Neuroimaging
Volume 181, Issue 3 , Pages 237-240 , 30 March 2010

Article Tools

* Image Usage & Resolution